306 related articles for article (PubMed ID: 25538167)
1. Specific antifungal susceptibility profiles of opportunists in the Fusarium fujikuroi complex.
Al-Hatmi AM; van Diepeningen AD; Curfs-Breuker I; de Hoog GS; Meis JF
J Antimicrob Chemother; 2015 Apr; 70(4):1068-71. PubMed ID: 25538167
[TBL] [Abstract][Full Text] [Related]
2. Phylogenetic Diversity and In Vitro Susceptibility Profiles of Human Pathogenic Members of the Fusarium fujikuroi Species Complex Isolated from South India.
Tupaki-Sreepurna A; Thanneru V; Natarajan S; Sharma S; Gopi A; Sundaram M; Kindo AJ
Mycopathologia; 2018 Jun; 183(3):529-540. PubMed ID: 29445920
[TBL] [Abstract][Full Text] [Related]
3. Genotyping and In Vitro Antifungal Susceptibility Testing of Fusarium Isolates from Onychomycosis in India.
Gupta C; Jongman M; Das S; Snehaa K; Bhattacharya SN; Seyedmousavi S; van Diepeningen AD
Mycopathologia; 2016 Aug; 181(7-8):497-504. PubMed ID: 27138574
[TBL] [Abstract][Full Text] [Related]
4. Fusarium keratitis in South India: causative agents, their antifungal susceptibilities and a rapid identification method for the Fusarium solani species complex.
Homa M; Shobana CS; Singh YR; Manikandan P; Selvam KP; Kredics L; Narendran V; Vágvölgyi C; Galgóczy L
Mycoses; 2013 Sep; 56(5):501-11. PubMed ID: 23437826
[TBL] [Abstract][Full Text] [Related]
5. In vitro resistance of clinical Fusarium species to amphotericin B and voriconazole using the EUCAST antifungal susceptibility method.
Taj-Aldeen SJ; Salah H; Al-Hatmi AM; Hamed M; Theelen B; van Diepeningen AD; Boekhout T; Lass-Flörl C
Diagn Microbiol Infect Dis; 2016 Aug; 85(4):438-43. PubMed ID: 27312690
[TBL] [Abstract][Full Text] [Related]
6. Antifungal susceptibility profile of clinical Fusarium spp. isolates identified by molecular methods.
Alastruey-Izquierdo A; Cuenca-Estrella M; Monzón A; Mellado E; Rodríguez-Tudela JL
J Antimicrob Chemother; 2008 Apr; 61(4):805-9. PubMed ID: 18263569
[TBL] [Abstract][Full Text] [Related]
7. [Molecular identification and in vitro susceptibility of Fusarium from fungal keratitis in central China].
Sun S; Lyu Q; Han L; Ma Q; Hu H; He S; Tao S; Zhang J; Zhang H; Wang L
Zhonghua Yan Ke Za Zhi; 2015 Sep; 51(9):660-7. PubMed ID: 26693650
[TBL] [Abstract][Full Text] [Related]
8. In vitro susceptibility of 188 clinical and environmental isolates of Aspergillus flavus for the new triazole isavuconazole and seven other antifungal drugs.
Shivaprakash MR; Geertsen E; Chakrabarti A; Mouton JW; Meis JF
Mycoses; 2011 Sep; 54(5):e583-9. PubMed ID: 21518026
[TBL] [Abstract][Full Text] [Related]
9. European Confederation of Medical Mycology (ECMM) epidemiological survey on invasive infections due to Fusarium species in Europe.
Tortorano AM; Prigitano A; Esposto MC; Arsic Arsenijevic V; Kolarovic J; Ivanovic D; Paripovic L; Klingspor L; Nordøy I; Hamal P; Arikan Akdagli S; Ossi C; Grancini A; Cavanna C; Lo Cascio G; Scarparo C; Candoni A; Caira M; Drogari Apiranthitou M;
Eur J Clin Microbiol Infect Dis; 2014 Sep; 33(9):1623-30. PubMed ID: 24791951
[TBL] [Abstract][Full Text] [Related]
10. Epidemiological aspects and characterization of the resistance profile of
Rosa PDD; Ramirez-Castrillon M; Borges R; Aquino V; Meneghello Fuentefria A; Zubaran Goldani L
J Med Microbiol; 2019 Oct; 68(10):1489-1496. PubMed ID: 31419209
[No Abstract] [Full Text] [Related]
11. In vitro combinations of natamycin with voriconazole, itraconazole and micafungin against clinical Fusarium strains causing keratitis.
Al-Hatmi AM; Meletiadis J; Curfs-Breuker I; Bonifaz A; Meis JF; De Hoog GS
J Antimicrob Chemother; 2016 Apr; 71(4):953-5. PubMed ID: 26702918
[TBL] [Abstract][Full Text] [Related]
12. In vitro evaluation of combination antifungal activity against Fusarium species isolated from ocular tissues of keratomycosis patients.
Li L; Wang Z; Li R; Luo S; Sun X
Am J Ophthalmol; 2008 Nov; 146(5):724-8. PubMed ID: 18707669
[TBL] [Abstract][Full Text] [Related]
13. Antifungal Susceptibility and Phylogeny of Opportunistic Members of the Genus Fusarium Causing Human Keratomycosis in South India.
Hassan AS; Al-Hatmi AM; Shobana CS; van Diepeningen AD; Kredics L; Vágvölgyi C; Homa M; Meis JF; de Hoog GS; Narendran V; Manikandan P;
Med Mycol; 2016 Mar; 54(3):287-94. PubMed ID: 26705832
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis.
Bueno JG; Martinez C; Zapata B; Sanclemente G; Gallego M; Mesa AC
Clin Exp Dermatol; 2010 Aug; 35(6):658-63. PubMed ID: 19874354
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of olorofim against clinical isolates of the Fusarium oxysporum and Fusarium solani species complexes.
Badali H; Cañete-Gibas C; Patterson H; Sanders C; Mermella B; Garcia V; Mele J; Fan H; Wiederhold NP
Mycoses; 2021 Jul; 64(7):748-752. PubMed ID: 33755988
[TBL] [Abstract][Full Text] [Related]
16. Amphotericin B and voriconazole susceptibility profiles for the Fusarium solani species complex: comparison between the E-test and CLSI M38-A2 microdilution methodology.
Debourgogne A; de Hoog S; Lozniewski A; Machouart M
Eur J Clin Microbiol Infect Dis; 2012 Apr; 31(4):615-8. PubMed ID: 21744037
[No Abstract] [Full Text] [Related]
17. Synergysm of voriconazole or itraconazole with other antifungal agents against species of Fusarium.
Spader TB; Venturini TP; Rossato L; Denardi LB; Cavalheiro PB; Botton SA; Santurio JM; Alves SH
Rev Iberoam Micol; 2013; 30(3):200-4. PubMed ID: 23402831
[TBL] [Abstract][Full Text] [Related]
18. International Evaluation of MIC Distributions and Epidemiological Cutoff Value (ECV) Definitions for Fusarium Species Identified by Molecular Methods for the CLSI Broth Microdilution Method.
Espinel-Ingroff A; Colombo AL; Cordoba S; Dufresne PJ; Fuller J; Ghannoum M; Gonzalez GM; Guarro J; Kidd SE; Meis JF; Melhem TM; Pelaez T; Pfaller MA; Szeszs MW; Takahaschi JP; Tortorano AM; Wiederhold NP; Turnidge J
Antimicrob Agents Chemother; 2016 Feb; 60(2):1079-84. PubMed ID: 26643334
[TBL] [Abstract][Full Text] [Related]
19. [Detection of virulence factors and antifungal susceptibilities of Fusarium strains isolated from keratitis cases].
Çuhadar T; Karabıçak N; Özdil T; Özgür D; Otağ F; Hızel K; Kalkancı A
Mikrobiyol Bul; 2018 Jul; 52(3):247-258. PubMed ID: 30156511
[TBL] [Abstract][Full Text] [Related]
20. Luliconazole, a highly effective imidazole, against Fusarium species complexes.
Gharaghani M; Hivary S; Taghipour S; Zarei-Mahmoudabadi A
Med Microbiol Immunol; 2020 Oct; 209(5):603-612. PubMed ID: 32253502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
